TGFB1 and invasive carcinoma: These collagens can be used as myoepithelial markers and are involved in the progression of canine mammary ductal carcinoma in situ to invasive carcinoma, mainly by activating the TGFβ signaling pathway, which is related to epithelial–mesenchymal transition (EMT), invasion, and stem cell characteristics [32,33,34].